Posted on April 7, 2022December 19, 2022 by tandemum [PRESENTATION] Advances in Preclinical Models for Angiogenesis and wet AMD [PRESENTATION] Advances in Preclinical Models for Angiogenesis and wet AMD Dr. Simon Kaja will present at the Wet AMD & DME Drug Development Summit 2022
Posted on September 7, 2022December 19, 2022 by tandemum [PRESENTATION] Evaluating Gene Therapy Assets in Preclinical Models [PRESENTATION] Evaluating Gene Therapy Assets in Preclinical Models Dr. Simon Kaja will present at the Gene Therapy for Ophthalmic Disorders conference 2022.
Posted on March 6, 2023March 6, 2023 by tandemum [PRESENTATION] Standardization of preclinical wet AMD models [PRESENTATION] Standardization of preclinical wet AMD models Dr. Jeff Jamison presented his take on ocular angiogenesis and relevant preclinical models at the 3rd Retinal Vascular Disease Drug Development Summit
Posted on November 2, 2021December 19, 2022 by tandemum [WEBINAR] AcuiSee – Rodent Visual Acuity Using Behavioral Conditioning [WEBINAR] AcuiSee – Rodent Visual Acuity Using Behavioral Conditioning Dr. Jeff Jamison will talk about “AcuiSee”, with which one can measure rodent vision based on an operant conditioning paradigm.
Posted on June 12, 2019September 18, 2020 by tandemum A retinal organotypic model for ex vivo neuroprotection studies A retinal organotypic model for ex vivo neuroprotection studies A recently published study by Experimentica Ltd. and its collaborators from the University of Tampere, Finland, shows that when the functional and morphological read-outs of retinal explant cultures are combined, it creates a valuable tool for studying retinal viability & degeneration, establishing a novel platform on which to test new therapeutic applications, aimed at treating […]
Posted on March 10, 2019September 18, 2020 by tandemum A summary of 2018 and a preview of 2019 A summary of 2018 and a preview of 2019 February 2019. Rome, Italy. The Eternal City astonishes with its beauty and magnificence, where one year in our lives seems like a blink of the eye. Whilst saying that, in 2018, ocular Contract Research Organization Experimentica Ltd. had some important happenings which laid down the grounds for further expansion and growth of the company in […]
Posted on October 7, 2019September 18, 2020 by tandemum Advances in preclinical in vivo imaging: OCT-Angiography of the rat retina Advances in preclinical in vivo imaging: OCT-Angiography of the rat retina Optical Coherence Tomography Angiography (OCT-A) is a novel non-invasive imaging technique to generate high resolution images of the retinal and choroidal microvasculature. By using motion contrast imaging, OCT-A can generate angiographic images without the need for intravenous dye injection.
Posted on November 10, 2023November 10, 2023 by Guillaume Demarne Animal Models for Dry AMD Therapeutic Development Animal Models for Dry AMD Therapeutic Development Dr. Jamison will present his take on relevant preclinical models at the 4th Annual Dry AMD Therapeutic Development Summit
Posted on October 6, 2020December 19, 2022 by tandemum Dr. Simon Kaja to discuss ocular angiogenesis models at ELRIG Drug Discovery 2020 Dr. Simon Kaja to discuss ocular angiogenesis models at ELRIG Drug Discovery 2020 Angiogenic ocular conditions are the leading cause of irreversible vision loss in developed countries. Dr. Kaja reviews the preclinical models available for drug discovery for ocular angiogenesis and discusses the challenges and opportunities associated with them.
Posted on October 27, 2020December 19, 2022 by tandemum Dr. Simon Kaja to present preclinical models at Dry AMD Therapeutics Summit Dr. Simon Kaja to present preclinical models at Dry AMD Therapeutics Summit Dr. Kaja reviews the preclinical models available for drug discovery for dry AMD and discusses the challenges and opportunities associated with them.
Posted on September 20, 2019September 18, 2020 by tandemum Experimentica at Bio Partnering event in Shanghai 2019 Experimentica at Bio Partnering event in Shanghai 2019 Experimentica Ltd. participates at Bio Partnering APAC conference in Shanghai, China, on September 24-25, 2019.
Posted on October 9, 2018September 18, 2020 by tandemum Experimentica at BioJapan 2018 Experimentica at BioJapan 2018 Experimentica Ltd. exhibits at BioJapan2018 partnering event in Pacifico Yokohama, Japan, on October 10 – October 12. Visit our booth A-07 or email bd@experimentica.com to set up a one-on-one meeting.
Posted on April 12, 2021December 19, 2022 by tandemum Experimentica attends 2021 ARVO Annual Meeting Experimentica attends 2021 ARVO Annual Meeting This year again the work of Experimentica's scientists at the forefront of Ophthalmology research will be featured at the 2021 ARVO Annual Meeting.
Posted on April 26, 2022December 19, 2022 by tandemum Experimentica attends 2022 ARVO Annual Meeting Experimentica attends 2022 ARVO Annual Meeting This year again the work of Experimentica's scientists at the forefront of Ophthalmology research will be featured at the 2022 ARVO Annual Meeting.
Posted on April 8, 2023April 18, 2023 by tandemum Experimentica attends ARVO 2023 (booth #1428) Experimentica attends ARVO 2023 (booth #1428) Experimentica is pleased to announce its participation in the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2023.
Posted on April 23, 2024April 23, 2024 by Guillaume Demarne Experimentica attends ARVO 2024 (booth #1440) Experimentica attends ARVO 2024 (booth #1440) Experimentica is pleased to announce its participation in the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2024.
Posted on October 12, 2020December 19, 2022 by tandemum Experimentica increases investment into R&D activities Experimentica increases investment into R&D activities Marc Cerrada-Gimenez, Ph.D. is appointed to Director of R&D Implementation as of October 2020.
Posted on May 22, 2020December 19, 2022 by tandemum Experimentica Ltd. acquires the Ophthalmic Contract Research Division from Ophthy-DS, Inc. Experimentica Ltd. acquires the Ophthalmic Contract Research Division from Ophthy-DS, Inc. Experimentica Ltd. announces the successful acquisition of the contract research division from US-based Ophthy-DS, Inc.
Posted on October 30, 2016September 18, 2020 by tandemum Experimentica Ltd. adds optic neuritis model to the Preclinical Model portfolio Experimentica Ltd. adds optic neuritis model to the Preclinical Model portfolio Species: mouseFollow-up period: up to 35 daysRoute of compound administration: topical, intravitreal, systemic. Functional and histological read-outs: In vivo imaging (optical coherence tomography (OCT)); In vivo functional assessment: a) electroretinography (pERG), b) visual evoked potentials (VEP); Morphological assessment (histology, IHC, EM, stereology); Molecular biology (ELISA, Western blotting, qPCR). Reference compounds (for MS-associated and ON phenotypes).
Posted on March 18, 2021March 18, 2021 by tandemum Experimentica Ltd. Announced Relocation of U.S. Laboratory Operations to Fort Worth, Texas Experimentica Ltd. Announced Relocation of U.S. Laboratory Operations to Fort Worth, Texas The relocation will strengthen Experimentica’s position as the premier preclinical ophthalmic CRO. It will also boost innovation capabilities through Industry-Academia collaboration, and support the Company’s growth in North America and globally.
Posted on April 14, 2023April 14, 2023 by tandemum Experimentica Ltd. Announces Strategic Expansion of Management Team with Three Key Appointments Experimentica Ltd. Announces Strategic Expansion of Management Team with Three Key Appointments The new management team will bolster Experimentica's leadership, driving innovation and growth in preclinical ocular models.
Posted on January 27, 2020December 19, 2022 by tandemum Experimentica Ltd. appoints new Director of Business Development Experimentica Ltd. appoints new Director of Business Development Guillaume Demarne, Pharm.D. is appointed to Director of Business Development as of January 2020.
Posted on October 12, 2020December 19, 2022 by tandemum Experimentica Ltd. appoints new Director of In Vivo Pharmacology Experimentica Ltd. appoints new Director of In Vivo Pharmacology Maria Vähätupa, Ph.D. is appointed to Director of In Vivo Pharmacology at our Kuopio, Finland site as of October 2020.
Posted on October 20, 2016September 18, 2020 by tandemum Experimentica Ltd. appoints new director of In Vivo pharmacology Experimentica Ltd. appoints new director of In Vivo pharmacology Kuopio, Finland, 20th October 2016: Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately.
Posted on January 25, 2017September 18, 2020 by tandemum Experimentica Ltd. appoints new director of laboratory animal research Experimentica Ltd. appoints new director of laboratory animal research Kuopio, Finland, 25th January 2017: Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Satu Mering, Ph.D. to Director Laboratory Animal Research. Dr. Mering received both her Masters and Ph.D. degree in Applied zoology from the University of Eastern Finland, where she served as Director of the Laboratory Animal Center […]
Posted on January 2, 2016September 18, 2020 by tandemum Experimentica Ltd. awarded EU Eurostars funding Experimentica Ltd. awarded EU Eurostars funding Kuopio, Finland and Vilnius, Lithuania, September 28th, 2015. Experimentica Ltd. (Finland), Ferentis UAB and State Research Institute Center for Physical Sciences and Technology (Department of Nanoengineering), Lithuania, were awarded a 534 364.00 € funding from the Eurostars programme to develop synthetic human-like corneal models as tools to aid eye drug assessment and screening, and reduce animal testing. […]
Posted on November 13, 2019September 18, 2020 by tandemum Experimentica Ltd. is a member of BioMelbourne Network Experimentica Ltd. is a member of BioMelbourne Network We are delighted to become a member of BioMelbourne Network together with other committed organisations engaged in biotechnology, medical technology, pharmaceuticals and health innovation.
Posted on November 22, 2018August 27, 2021 by tandemum Experimentica Ltd. opens a new R&D site in Lithuania Experimentica Ltd. opens a new R&D site in Lithuania Experimentica Ltd. opens a new R&D site in Vilnius, Lithuania
Posted on June 27, 2019September 18, 2020 by tandemum Experimentica Ltd. participates in ORBITAL, an EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award Experimentica Ltd. participates in ORBITAL, an EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network award Experimentica Ltd. is pleased to announce its participation as beneficiary in the ORBITAL consortium who were awarded a Horizon 2020 framework Marie Sklodowska-Curie Innovative Training Network award. The ORBITAL (Ocular Research By Integrated Training And Learning) consortium, led by Dr. Laurence Fitzhenry at The Waterford Institute, Ireland, received €4M from the European Training Network (ETN) programme to […]
Posted on September 7, 2018September 18, 2020 by tandemum Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting Chief Operating Officer of Experimentica Ltd. will present an oral presentation entitled: Protection by a metalloporphyrin superoxide dismutase mimetic against signs of dry-eye disease Dr Simon Kaja – […]
Posted on July 25, 2019September 18, 2020 by tandemum Experimentica Ltd. presents strategic roadmap and announces €3,05M investment in artificial intelligence for preclinical efficacy and safety testing of ophthalmic drug candidates Experimentica Ltd. presents strategic roadmap and announces €3,05M investment in artificial intelligence for preclinical efficacy and safety testing of ophthalmic drug candidates Experimentica Ltd. revealed its strategic plan that outlines a roadmap for the development of artificial intelligence (AI)-based algorithms aimed at quantifying and predicting the preclinical efficacy and safety of next-generation drugs for ophthalmic indications.
Posted on April 17, 2017September 18, 2020 by tandemum Experimentica Ltd. received EU funding Experimentica Ltd. received EU funding March 17th, 2017. Centre for Economic Development, Transport and the Environment, awards Experimentica Ltd. a funding of over 200,000 €.
Posted on September 28, 2015September 18, 2020 by tandemum Experimentica Ltd. received EU Grant Experimentica Ltd. received EU Grant On August 31 st, 2015, The North Savo ELY Centre for Economic Development, Transport and the Environment, awarded Experimentica Ltd. funding supporting dry-eye induction system development and validation.
Posted on September 22, 2020September 22, 2020 by Guillaume Demarne Experimentica Ltd. receives French CIR accreditation Experimentica Ltd. receives French CIR accreditation From now on, France's Crédit d'Impôt Recherche incentive can cover up to 30% of R&D expenses incurred by innovative French pharma and biotech companies working with us.
Posted on January 22, 2024January 22, 2024 by Guillaume Demarne Experimentica Ltd. renews French CIR accreditation Experimentica Ltd. renews French CIR accreditation France's Crédit d'Impôt Recherche incentive can cover up to 30% of R&D expenses incurred by innovative French pharma and biotech companies working with Experimentica.
Posted on August 15, 2018September 18, 2020 by tandemum Experimentica Ltd. Sponsors the 2018 SILK-Elsemay Björn Symposium Experimentica Ltd. Sponsors the 2018 SILK-Elsemay Björn Symposium [Kuopio, Finland and Chicago, USA – August 14th, 2018] – Experimentica Ltd. is pleased to announce its co-sponsorship and participation in this year’s SILK – Elsemay Björn Symposium. This yearly international symposium is to be held in Tampere, Finland at the Jarmo Visakorpi Auditorium, Arvo Ylpön katu 34, Tampere on August 20th, 2018. Experimentica Ltd. is a co-sponsor with SILK […]
Posted on May 5, 2023May 15, 2023 by tandemum Experimentica Science Day | May 26, 2023, Vilnius, LT Experimentica Science Day | May 26, 2023, Vilnius, LT Experimentica Science Day: connect with top preclinical Ophthalmology Professors and Industry Experts for insights and discoveries
Posted on March 7, 2023September 14, 2024 by tandemum Experimentica will attend 62nd SOT and ToxExpo | Booth #1532 Experimentica will attend 62nd SOT and ToxExpo | Booth #1532 Meet us at booth #1532 and find out more about Experimentica's R&D and services in ocular Toxicology and PK.
Posted on January 31, 2023September 14, 2024 by tandemum Experimentica will attend ISER 2023 Experimentica will attend ISER 2023 Back to ISER - The work of Experimentica's scientists at the forefront of Ophthalmology research will be featured at the XXV biennial meeting of the International Society of Eye Research.
Posted on October 29, 2021December 19, 2022 by tandemum Experimentica will present at Neuroscience 2021 Experimentica will present at Neuroscience 2021 This year the work of Experimentica's scientists at the forefront of Ophthalmology research will be featured at the Neuroscience 2021.
Posted on June 16, 2022November 7, 2022 by tandemum Experimentica-led NeoVasculoStop© Consortium Awarded 3 M€ European Innovation Council Pathfinder Grant Experimentica-led NeoVasculoStop© Consortium Awarded 3 M€ European Innovation Council Pathfinder Grant Focus is to develop innovative oral treatments for retinal diseases caused by neovascularization and to improve the safety of anti-angiogenic therapies for patients.
Posted on March 22, 2017September 18, 2020 by tandemum Experimentica’s team co-authors a scientific publication Experimentica’s team co-authors a scientific publication The neuronal ceroid lipofuscinoses (NCL), also known as Batten disease, are the most common group of neurodegenerative diseases among children. In the recently published study co-authored by Experimentica Ltd., the retinopathy of CLN5 disease is thoroughly described in the mouse model.
Posted on May 2, 2022August 26, 2022 by Justina Dragunaite Implementing the new project RETINA-R Implementing the new project RETINA-R UAB Experimentica implementing project „Innovative ophthalmic preclinical animal models for advanced drug research (retina-R)” (No. 01.2.1-LVPA-K-923-03-0001), financed from the European Union Structural Funds and budget of the Republic of Lithuania.
Posted on April 7, 2019September 18, 2020 by tandemum In vivo imaging in the rat oxygen-induced retinopathy model In vivo imaging in the rat oxygen-induced retinopathy model Background Oxygen-induced retinopathy model mimics retinopathy of prematurity and human ischemic retinopathies. Retinopathy of prematurity (ROP) affects premature infants that weigh less than 1,250 grams or that are born before 31 weeks of gestation. ROP is a potentially blinding eye disorder. As advances in care for premature neonates have reduced the impact of ROP, a […]
Posted on September 27, 2021December 19, 2022 by tandemum Jeff Jamison receives Department Merit Award from Michigan Engineering Jeff Jamison receives Department Merit Award from Michigan Engineering Our colleague Jeff Jamison last week received the Biomedical Engineering Department Merit Award from University of Michigan College of Engineering. Michigan Engineering honors those alumni who personify the College’s tradition of excellence. Department Merit Awards recognize distinction at the academic department level. Congratulations from all of us at Experimentica, Jeff!
Posted on October 6, 2024October 6, 2024 by Algirdas Markauskas Kon’nichiwa BioJapan 2024! Kon’nichiwa BioJapan 2024! Experimentica will be presenting preclinical ocular models at BioJapan 2024 in Yokohama, Oct. 9-11, 2024.
Posted on September 10, 2019September 18, 2020 by tandemum Let’s meet at European Retina Meeting 2019! Let’s meet at European Retina Meeting 2019! Follow Experimentica Ltd. at the ERM2019, September 12—14, 2019, Helsinki, Finland. If you are attending, be sure to stop by golden sponsor booth No. 1 to meet our team.
Posted on October 25, 2019September 18, 2020 by tandemum Let’s meet at Global Biotech VIP Week in Melbourne, 2019 Let’s meet at Global Biotech VIP Week in Melbourne, 2019 Experimentica’s CEO Giedrius Kalesnykas attends Global Biotech VIP Week in Melbourne, Australia.
Posted on September 10, 2024September 10, 2024 by Guillaume Demarne Meet Experimentica at the 5th Gene Therapy for Ophthalmic Disorders Summit in Boston Meet Experimentica at the 5th Gene Therapy for Ophthalmic Disorders Summit in Boston Experimentica attends the 5th Gene Therapy for Ophthalmic Disorders Summit in Boston, Sept. 10-12, 2024.
Posted on September 18, 2018September 18, 2020 by tandemum Meet Experimentica Ltd. in Vienna at the EURETINA 2018, Congress Meet Experimentica Ltd. in Vienna at the EURETINA 2018, Congress Experimentica representatives and scientists will be attending the 18th EURETINA Congress in Vienna, Austria. The event takes place from the 20th– 23rd of September at the Messe Wien Exhibition & Congress Centre: Entrance D, Trabrennstraße 7, 1021 Vienna, Austria U2. (Subway station: Krieau) To contact an Experimentica representative please e-mail info@experimentica.com [Kuopio, Finland and Chicago, USA – September 18th, 2018]– Experimentica […]
Posted on October 3, 2018September 18, 2020 by tandemum Meet Experimentica Ltd. team at EVER 2018 Meet Experimentica Ltd. team at EVER 2018 Meet Experimentica Ltd. team at EVER2018.
Posted on April 23, 2019September 18, 2020 by tandemum Meet Experimentica team at ARVO 2019 Meet Experimentica team at ARVO 2019 Experimentica Ltd. exhibits at ARVO 2019 conference in Vancouver, Canada.
Posted on September 6, 2019September 18, 2020 by tandemum Meet Experimentica team at NLSDays2019 Meet Experimentica team at NLSDays2019 Experimentica Ltd. Team participates at Nordic Life Science Days.
Posted on March 3, 2017September 18, 2020 by tandemum Meet Experimentica’s management team at Arvo 2017 Meet Experimentica’s management team at Arvo 2017 Experimentica Ltd. presents novel findings from EU-funded Eurostars’ project on synthetic human-like corneal models (#4337) and exhibits at The Association for Research in Vision and Ophthalmology (ARVO) conference in Baltimore, MD, USA, May 7-11, 2017.
Posted on February 2, 2017September 18, 2020 by tandemum Meet us at Aopt 2017 meeting Meet us at Aopt 2017 meeting Experimentica team attends The Association for Ocular Pharmacology and Therapeutics (AOPT) meeting in Florence, Italy on February 16-19th, 2017.
Posted on April 27, 2018September 18, 2020 by tandemum Meet Us at ARVO 2018 Meet Us at ARVO 2018 Email info@experimentica.com to set up a One-on-One meeting.
Posted on May 31, 2021December 19, 2022 by tandemum Meet us at BIO Digital 2021 International Convention Meet us at BIO Digital 2021 International Convention We want to hear about your preclinical ocular drug developments! Meet our BD Director Guillaume Demarne at BIO Digital 2021 Int’l Convention.
Posted on November 3, 2024November 3, 2024 by Algirdas Markauskas Meet Us at Bio-Europe 2024! Meet Us at Bio-Europe 2024! Experimentica will be presenting preclinical ocular models at Bio-Europe 2024 in Stockholm, Nov. 4-6, 2024.
Posted on March 30, 2017September 18, 2020 by tandemum Meet us at Chicago SFN Annual Meeting Meet us at Chicago SFN Annual Meeting Experimentica Ltd. is a proud sponsor of the Chicago SFN 2017 annual meeting. Visit us tomorrow, March 31st, 2017, at Northwestern Memorial Hospital Conference Center or schedule a meeting to explore our capabilities.
Posted on November 18, 2019September 18, 2020 by tandemum Meet us at SMi’s Ophthalmic Drugs Conference 2019 in London, UK, 2019 Meet us at SMi’s Ophthalmic Drugs Conference 2019 in London, UK, 2019 We are pleased to be a part of the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on the 18th-20th November 2019 in London, UK.
Posted on March 9, 2018September 18, 2020 by tandemum Meet us at the 2018 Bio Asia International conference Meet us at the 2018 Bio Asia International conference Our CEO Dr. Giedrius Kalesnykas and CSO Dr. Simon Kaja will participate at the 2018 BIO Asia International Conference, to be held in Tokyo, Japan, March 19-20, 2018.
Posted on January 15, 2019September 18, 2020 by tandemum New Board of Directors announced New Board of Directors announced Experimentica Ltd., a global contract research organization that specializes in preclinical models for ophthalmic diseases, is pleased to announce its new Board of Directors.
Posted on January 10, 2019September 18, 2020 by tandemum New insights to the supporting mechanism of fluid management in the neural retina New insights to the supporting mechanism of fluid management in the neural retina Angiopoietin-4 was identified as the first growth factor having a venous-specific function in the mouse retina, according to a publication co-authored by Experimentica Ltd.
Posted on January 25, 2020September 18, 2020 by tandemum Professional Development Programme at Experimentica in 2020 Professional Development Programme at Experimentica in 2020 The professional development of our talented employees in 2020 will be co-funded by the European Social Fund Agency.
Posted on May 4, 2020December 19, 2022 by tandemum Refining Ocular Preclinical Models – Webinar Series Refining Ocular Preclinical Models – Webinar Series Ever wondered how Experimentica's scientists refine and improve preclinical ocular models? Join our first webinar series starting May 6, 2020.
Posted on June 5, 2019September 18, 2020 by tandemum Thank you for visiting us at ARVO 2019 conference Thank you for visiting us at ARVO 2019 conference Thank you, everyone, for visiting our booth at ARVO 2019 in Vancouver, Canada, and our poster presentations on choroidal neovascularization and corneal permeability models!
Posted on July 20, 2016September 18, 2020 by tandemum The End of BAC containing ophthalmic formulations? The End of BAC containing ophthalmic formulations? Acute cytotoxic effects of the pharmaceutical excipients benzalkonium chloride (BAC), macrogolglycerol hydroxystearate (MGHS40), polysorbate 80 (PS80) and marketed ophthalmic formulations (Lumigan(R), Monoprost(R), Taflotan(R), Travatan(R), Xalatan(R)) containing these excipients were tested. Human corneal epithelial cell (HCE-T) viability was assessed by measuring the reduction of resazurin to highly fluorescent resorufin. The study was fully funded by Experimentica […]
Posted on September 17, 2019September 18, 2020 by tandemum Visit our poster in 17th European Congress of Toxicologic Pathology Visit our poster in 17th European Congress of Toxicologic Pathology A chance for ESTP 2019 participants! Experimentica’s partner Aiforia Technologies Oy will present joint poster dedicated for illustration of the effectivity of Aflibercept, administered systemically and for initial demonstration of convolutional neural network trained to recognize and quantify choroidal neovascularization lesion using Aiforia® Cloud. The poster will be presented during 17-19th of September, 2019 in 17th European Congress of Toxicologic Pathology, Cologne, […]
Posted on September 12, 2019September 18, 2020 by tandemum Welcome to poster session in European Retina Meeting 2019 Welcome to poster session in European Retina Meeting 2019 ERM2019 attendees!
